Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Sep 26;16(1):1033-1040.
doi: 10.1159/000533835. eCollection 2023 Jan-Dec.

Feminizing Adrenocortical Tumor with Multiple Recurrences: A Case Report

Affiliations
Case Reports

Feminizing Adrenocortical Tumor with Multiple Recurrences: A Case Report

Joseph M Rich et al. Case Rep Oncol. .

Abstract

Feminizing adrenocortical tumors (FATs) are exceptionally rare primary adrenal neoplasms that cause high estrogen and low testosterone levels. They are most common in adult males, typically presenting with gynecomastia, hypogonadism, and weight loss. They are almost always malignant, with a poor prognosis and a high recurrence rate. We report a case of a 35-year-old man with an adrenal FAT with high estrogen (181 pg/mL) and low testosterone (37 ng/dL) who presented with gynecomastia, erectile dysfunction, subclinical Cushing syndrome, and pain localizing to different regions of the torso. There was no evidence of metastatic disease initially as seen by visualization of a well-marginated mass on computed tomography scan. Surgical resection of the FAT was performed, and the mass was confirmed to be a low-grade tumor. Clinical symptoms were resolved after surgery. Despite complete resection with negative margins, the patient subsequently had two separate local metastatic recurrences within a few years, treated with a combination of further surgery and medical intervention. This case highlights the unique features of an exceedingly rare adrenal tumor and stresses the importance of early detection and vigilant surveillance following resection due to high recurrence rates.

Keywords: Estrogen-secreting tumor; Feminizing adrenocortical tumor; Gynecomastia.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1.
Fig. 1.
Axial (a) and coronal (b) contrast-enhanced CT scans upon diagnosis. There is a large, heterogeneous, predominantly soft tissue mass replacing the right adrenal and displacing the kidney and liver. The mass (blue arrows) is well-marginated with no obvious infiltration into surrounding tissues and no intra-venous extension. A few intratumoral streak-like linear densities are from neovascularity. Axial post-contrast T1-weighted MR image (c) depicts the heterogeneous nature of the well-marginated right adrenal tumor (blue arrow).
Fig. 2.
Fig. 2.
Pathological findings of the primary tumor specimen. a Gross tumor demonstrating predominantly yellow color with areas of hemorrhage and necrosis. bc Light microscopy of the tumor showing adrenal cortical carcinoma with necrosis ×20 (b) and mitosis (c).
Fig. 3.
Fig. 3.
Axial CT scan 18 months after surgery revealing a growing perinephric nodule (blue arrow) consistent with recurrent/locally metastatic disease (the inferior tip of the right hepatic lobe is seen lateral to the right kidney).

References

    1. Lirov R, Tobias E, Lerario AM, Hammer GD. Adrenal tumors. 10th ed. In: DeVita VT, Lawrence TS, Rosenberg SA, editors. DeVita, hellman, and rosenberg’s cancer: principles and practice of oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2015. [Chapter 84].
    1. Reincke M. Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am. 2000 Mar;29(1):43–56. 10.1016/s0889-8529(05)70115-8. - DOI - PubMed
    1. Moreno S, Guillermo M, Decoulx M, Dewailly D, Bresson R, Proye C. Feminizing adreno-cortical carcinomas in male adults. A dire prognosis. Three cases in a series of 801 adrenalectomies and review of the literature. Ann Endocrinol. 2006 Mar;67(1):32–8. 10.1016/s0003-4266(06)72537-9. - DOI - PubMed
    1. Chentli F, Bekkaye I, Azzoug S. Feminizing adrenocortical tumors: literature review. Indian J Endocrinol Metab. 2015;19(3):332–9. 10.4103/2230-8210.152764. - DOI - PMC - PubMed
    1. Vurallı D, Gönç N, Özön A, Ekinci S, Doğan HS, Tekgül S, et al. . Feminizing adrenocortical tumors as a rare etiology of isosexual/contrasexual pseudopuberty. J Clin Res Pediatr Endocrinol. 2022 Mar 3;14(1):17–28. 10.4274/jcrpe.galenos.2021.2021.0170. - DOI - PMC - PubMed

Publication types